Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

NovoLog approved for pregnancy Category B rating

Feb. 2, 2007

Novel andrographolide analogue DRF-3173 decreases body weight in hyperlipidemic mice

Feb. 2, 2007

Ipsen granted Adrovance marketing rights for France

Feb. 1, 2007

Leptin increases food intake in rats via reductions in the firing of VTA dopamine neurons

Feb. 1, 2007

FGF-19 increases energy expenditure and reduces fat mass in diet-induced obese mice

Feb. 1, 2007

Mirena approved in Japan

Jan. 31, 2007

DiabeCell cleared for Russian study in type 1 diabetes

Jan. 31, 2007

Aranesp increases risk of death in cancer patients not receiving treatment

Jan. 31, 2007

Novel antidiabetic agents disclosed in recent patent literature

Jan. 30, 2007

Somavert approved for acromegaly in Japan

Jan. 30, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...